Description
Developer of anti-infective drugs created to cure various bacterial diseases. The company is currently operating in stealth mode.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Angel (individual) | 14-Jan-2020 | $421K | 00000 | Completed | Stealth |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Clayton Duncan | Chief Executive Officer & Board Member | ||
Moise Khayrallah | Executive Officer & Board Member | ||
Pei Zhou | Executive Officer & Board Member |
Name | Representing | Role | Since |
---|---|---|---|
Clayton Duncan | Valanbio Therapeutics | Chief Executive Officer & Board Member | 000 0000 |
Eric Toone | Valanbio Therapeutics | Board Member | 000 0000 |
Moise Khayrallah | Valanbio Therapeutics | Executive Officer & Board Member | 000 0000 |
Pei Zhou | Valanbio Therapeutics | Executive Officer & Board Member | 000 0000 |
Sam Hopkins | Valanbio Therapeutics | Board Member | 000 0000 |